The evaluation of the therapeutic effects of low dose edoxaban in atrial fibrillation patients: a single centre, case series study

• At: Seville (Spain) (2022)
• Type: Poster
• Poster code: HPS-100
• By: HUANG, Ching-Chih ()
• Co-author(s): Ms Shu-Chen Lai, Pharmacist (Department of Pharmacy, Tungs’Taichung MetroHarbor Hospital, Taichung, Taiwan China / Taichung City New Pharmacist Association, Taichung, Taiwan)
  Mr Pei-Liang Chen, Department of Pharmacy (Department of Pharmacy, Tungs’Taichung MetroHarbor Hospital, Taichung, Taiwan China / Taichung City New Pharmacist Association, Taichung, Taiwan)
  Mr Po-I Chen, Department of Pharmacy (Department of Pharmacy, Tungs’Taichung MetroHarbor Hospital, Taichung, Taiwan China / Taichung City New Pharmacist Association, Taichung, Taiwan)
  Ms Ching-Chih Huang, Pharmacist (Department of Pharmacy, Tungs’Taichung MetroHarbor Hospital, Taichung, Taiwan China / Taichung City New Pharmacist Association, Taichung, Taiwan)
  
• Abstract:

  Background information：
  Atrial fibrillation (AF) is an independent and cursical risk factor to stroke and systemic embolism. The use of Edoxaban, a non–vitamin K antagonist oral anticoagulant (NOAC), with 60 mg or 30 mg daily is noninferior to the well-managed use of Warfarin when it comes to the therapeutic effects to AF patients.
  
  Purpose：
  To..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login